Profile
Robert Coutts is currently Director at Achilles Therapeutics UK Ltd. since 2021 and Chief Financial Officer at Achilles Therapeutics Plc since 2020.
Former roles include Financial Controller at Syncona Ltd. from 2015 to 2017 and Accountant at KPMG Audit Plc from 2007 to 2012.
Education includes graduate studies at Bayes Business School and undergraduate studies at New College Oxford.
Robert Coutts active positions
| Companies | Position | Start |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Director of Finance/CFO | 2020-10-31 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Director/Board Member | 2021-01-10 |
Former positions of Robert Coutts
| Companies | Position | End |
|---|---|---|
| SYNCONA LIMITED | Comptroller/Controller/Auditor | 2017-10-31 |
KPMG Audit Plc
KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 2012-06-30 |
Training of Robert Coutts
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Syncona Ltd.
Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Bayes Business School
Bayes Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Audit Plc
KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
New College Oxford
New College Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Robert Coutts
















